140 related articles for article (PubMed ID: 26210487)
1. Advanced glycation end products accelerate arteriosclerosis after renal transplantation through the AGE/RAGE/ILK pathway.
Liu X; Liu K; Wang Z; Liu C; Han Z; Tao J; Lu P; Wang J; Wu B; Huang Z; Yin C; Gu M; Tan R
Exp Mol Pathol; 2015 Oct; 99(2):312-9. PubMed ID: 26210487
[TBL] [Abstract][Full Text] [Related]
2. Effect of sirolimus on arteriosclerosis induced by advanced glycation end products via inhibition of the ILK/mTOR pathway in kidney transplantation recipients.
Xu Z; Liu X; Wang Z; Tao J; Han Z; Gu M; Zhang W; Tan R
Eur J Pharmacol; 2017 Oct; 813():1-9. PubMed ID: 28669853
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-products enhance calcification in vascular smooth muscle cells.
Ren X; Shao H; Wei Q; Sun Z; Liu N
J Int Med Res; 2009; 37(3):847-54. PubMed ID: 19589269
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation.
Li JJ; Han M; Wen JK; Li AY
Biochem Biophys Res Commun; 2007 Apr; 356(1):13-9. PubMed ID: 17336930
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.
Li JH; Wang W; Huang XR; Oldfield M; Schmidt AM; Cooper ME; Lan HY
Am J Pathol; 2004 Apr; 164(4):1389-97. PubMed ID: 15039226
[TBL] [Abstract][Full Text] [Related]
7. Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.
Ballinger ML; Thomas MC; Nigro J; Ivey ME; Dilley RJ; Little PJ
Kidney Int; 2005 Dec; 68(6):2756-65. PubMed ID: 16316350
[TBL] [Abstract][Full Text] [Related]
8. Effect of crocetin on vascular smooth muscle cells migration induced by advanced glycosylation end products.
Xiang M; Yang R; Zhang Y; Wu P; Wang L; Gao Z; Wang J
Microvasc Res; 2017 Jul; 112():30-36. PubMed ID: 28209519
[TBL] [Abstract][Full Text] [Related]
9. Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium.
Nam MH; Son WR; Lee YS; Lee KW
Cell Commun Adhes; 2015; 22(2-6):67-78. PubMed ID: 27602595
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ).
Chen M; Li H; Wang G; Shen X; Zhao S; Su W
Metabolism; 2016 Apr; 65(4):441-53. PubMed ID: 26975536
[TBL] [Abstract][Full Text] [Related]
11. Apocynin decreases AGEs-induced stimulation of NF-κB protein expression in vascular smooth muscle cells from GK rats.
Silva CO; da Silva OA; Duarte GP; Descomps B; Lahlou S
Pharm Biol; 2015 Apr; 53(4):488-93. PubMed ID: 25471209
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products promote proliferation and suppress autophagy via reduction of Cathepsin D in rat vascular smooth muscle cells.
Ma M; Guo X; Chang Y; Li C; Meng X; Li S; Du ZX; Wang HQ; Sun Y
Mol Cell Biochem; 2015 May; 403(1-2):73-83. PubMed ID: 25673507
[TBL] [Abstract][Full Text] [Related]
13. Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats.
de Oliveira Silva C; Delbosc S; Araïs C; Monnier L; Cristol JP; Pares-Herbute N
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):23-30. PubMed ID: 17127041
[TBL] [Abstract][Full Text] [Related]
14. IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release.
Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
Vascul Pharmacol; 2015 Sep; 72():108-17. PubMed ID: 25956731
[TBL] [Abstract][Full Text] [Related]
15. Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat.
Sun M; Yokoyama M; Ishiwata T; Asano G
Int J Exp Pathol; 1998 Aug; 79(4):207-22. PubMed ID: 9797717
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products promote the proliferation and migration of primary rat vascular smooth muscle cells via the upregulation of BAG3.
Li C; Chang Y; Li Y; Chen S; Chen Y; Ye N; Dai D; Sun Y
Int J Mol Med; 2017 May; 39(5):1242-1254. PubMed ID: 28350077
[TBL] [Abstract][Full Text] [Related]
17. [Role of peroxisome proliferators activated receptor gamma in mediating proliferation of rat vascular smooth muscle cells induced by advanced glycation end products].
Yuan XC; Liu NF; Yan JC; Zhang X
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):940-4. PubMed ID: 16266488
[TBL] [Abstract][Full Text] [Related]
18. Relationship of advanced glycation end products and their receptor to pelvic organ prolapse.
Chen Y; Huang J; Hu C; Hua K
Int J Clin Exp Pathol; 2015; 8(3):2288-99. PubMed ID: 26045736
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells.
Yuan X; Liu N
J Genet Genomics; 2011 May; 38(5):193-200. PubMed ID: 21621740
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products-induced vascular calcification is mediated by oxidative stress: functional roles of NAD(P)H-oxidase.
Tada Y; Yano S; Yamaguchi T; Okazaki K; Ogawa N; Morita M; Sugimoto T
Horm Metab Res; 2013 Apr; 45(4):267-72. PubMed ID: 23225244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
